Your session is about to expire
← Back to Search
Behavioural Intervention
rTMS for Depression
N/A
Waitlist Available
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 days
Awards & highlights
Summary
This trial is testing whether rTMS to the OFC is more effective than rTMS to the dlPFC in treating MDD.
Who is the study for?
This trial is for adults aged 18-60 with Major Depressive Disorder, as indicated by specific depression scales. Participants must understand and consent to the study's procedures, not be pregnant or nursing if female, and have no metal implants that interfere with MRI or TMS.
What is being tested?
The trial tests repetitive Transcranial Magnetic Stimulation (rTMS) on a brain area called the orbitofrontal cortex in people with depression who haven't fully responded to other treatments. It aims to see if rTMS can better alleviate depressive symptoms.
What are the potential side effects?
Potential side effects of rTMS may include discomfort at the stimulation site, headache, lightheadedness, seizures (very rare), and temporary hearing changes due to the noise during treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 20 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Functional connectivity of orbital frontal cortex (OFC)
Outcome Changes in MDD subjects
Trial Design
1Treatment groups
Experimental Treatment
Group I: rTMSExperimental Treatment1 Intervention
20 sessions of rTMS
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Repetitive Transcranial Magnetic Stimulation
2013
Completed Phase 3
~1170
Find a Location
Who is running the clinical trial?
Baylor College of MedicineLead Sponsor
1,018 Previous Clinical Trials
6,031,379 Total Patients Enrolled
30 Trials studying Depression
7,239 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not pregnant or breastfeeding during the fMRI and TMS treatment periods.I cannot tolerate TMS treatment.I am between 18 and 60 years old.I have been diagnosed with Major Depressive Disorder.I speak English.I do not have any unstable medical conditions like AIDS, acute hepatitis, or unstable diabetes.I am not pregnant or nursing.I am unable to give my consent for participation.
Research Study Groups:
This trial has the following groups:- Group 1: rTMS
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger